NCT04265105 is a Phase 2, PHASE3 clinical trial of fluticasone-vilanterol in Asthma, sponsored by Royal College of Surgeons in Ireland - Medical University of Bahrain.

Who is sponsoring NCT04265105?

NCT04265105 is sponsored by Royal College of Surgeons in Ireland - Medical University of Bahrain.

What drugs are being tested in NCT04265105?

Interventions in NCT04265105: fluticasone-vilanterol, Standard Preparation.

Is NCT04265105 still recruiting?

NCT04265105 is currently completed. Last updated 31 March 2023.

Last reviewed 2023-03-31 · How we verify

NCT04265105

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

Completed Phase 2, PHASE3 Last updated 31 March 2023

What this trial tests

Phase 2, PHASE3 trial testing fluticasone-vilanterol in Asthma in 18 participants. Completed in 18 January 2023.

Timeline

22 December 2021

Primary endpoint
18 January 2023

18 January 2023

Quick facts

Lead sponsor	Royal College of Surgeons in Ireland - Medical University of Bahrain
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	18
Start date	22 December 2021
Primary completion	18 January 2023
Estimated completion	18 January 2023
Sites	1 location across Bahrain

Drugs / interventions tested

fluticasone-vilanterol — full drug profile →
Standard Preparation — full drug profile →

Conditions studied

Asthma — all drugs for Asthma →

Sponsor

Royal College of Surgeons in Ireland - Medical University of Bahrain

Who can join

Adults 21 to 75, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will test the superiority of Superiority Trial of Fluticasone-Vilanterol as needed in mild asthma compared to standard of care

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A feasibility randomized controlled superiority trial of fluticasone-vilanterol once daily use for the treatment of mild asthma in adults
Jassim G, Morcos M, O’Connell M, Cunningham W. · · 2023 · DOI 10.12688/f1000research.136628.1

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting

Other Royal College of Surgeons in Ireland - Medical University of Bahrain trials

Trials by the same sponsor.

NCT07383337 — Comparing the Olfactory Perception of a Fragrance-Loaded SpECs Over Time · NA · not yet recruiting
NCT07172997 — Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers · active not recruiting
NCT06069258 — Movement Behaviours Among Bahraini Diabetics · recruiting
NCT06652867 — Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event · completed
NCT04616066 — Date Fruit Effects in Type 2 Diabetes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04265105 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Royal College of Surgeons in Ireland - Medical University of Bahrain
Last refreshed: 31 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04265105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing